Find uplifting stories about heroes, innovations, and solutions
7233 results for "schizophrenia treatment"
Scientists at Northwestern University discovered a biomarker that could lead to the first effective treatment for cognitive symptoms of schizophrenia, potentially helping millions live independently. A single injection improved brain function in early tests with no negative side effects.
A Dubai hospital now provides a groundbreaking medication that requires dosing just twice a year, making life easier for people living with schizophrenia. The treatment is already helping patients stay healthy while dramatically reducing hospital readmissions.
The FDA just approved BYSANTI, a new medication offering hope to millions of Americans living with schizophrenia and bipolar I disorder. Built on more than a decade of proven safety data, this treatment represents a faster path to innovation in mental health care.
Northwestern University researchers discovered a biomarker that could finally treat the cognitive symptoms of schizophrenia that current medications miss. A synthetic protein tested in animal models successfully reversed brain abnormalities linked to memory and thinking problems.
Scientists in Israel successfully reversed schizophrenia symptoms in lab trials using targeted brain stimulation, offering hope for millions who don't respond to current treatments. The breakthrough could transform care for one-third of the world's 21 million schizophrenia patients.
A groundbreaking study shows adding brexpiprazole to existing treatments helps people with schizophrenia think faster and process information better. The discovery opens new doors for treating one of the condition's most disabling symptoms that affects daily life and work.
A groundbreaking medication approved in 2024 treats schizophrenia through an entirely new approach, targeting brain receptors never before used in mental health treatment. The drug shows promise for managing symptoms without the severe metabolic side effects that have plagued patients for decades.
Millions living with serious mental illness just got a new treatment option. The FDA approved Bysanti, offering hope for those managing bipolar 1 disorder and schizophrenia.
Scientists at MIT identified a gene mutation that causes the brain to get stuck on outdated beliefs and successfully reversed the effect in mice. The discovery opens promising new treatment paths for cognitive symptoms in schizophrenia patients.
The FDA just approved a new treatment option for people living with bipolar 1 disorder and schizophrenia. Bysanti offers fresh hope for millions managing these challenging mental health conditions.
A new biotech company just launched with $106 million to bring promising brain disorder treatments to Americans. Tortugas Neuroscience is testing four drugs for conditions that affect millions, including schizophrenia, tinnitus, and epilepsy.
Researchers discovered over 100 new genes linked to schizophrenia by studying African ancestry populations for the first time. The breakthrough could help doctors spot warning signs earlier and develop better treatments.
Researchers in Israel used deep-brain stimulation to dramatically reduce hallucinations in patients with treatment-resistant schizophrenia, opening a new frontier for the 30% who don't respond to medication. One patient said the voices that controlled his life finally became quiet.
Groundbreaking conversations are changing how families support loved ones with schizophrenia, one of the most misunderstood mental health conditions. Advocates say simple connection—sharing meals, showing up, listening without judgment—makes all the difference.
UCSF researchers are using brain scans to identify who will develop schizophrenia years before psychosis starts, potentially preventing the disease entirely. Early detection could transform treatment for the 1% of people worldwide affected by this condition.
A Pulitzer-nominated story reveals how a woman's schizophrenia mysteriously disappeared after cancer treatment, offering new hope for mental illness research. The deeply reported piece shows what happens when journalists build trust to tell nuanced recovery stories.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
A groundbreaking opera premiering at UCLA tells the true story of renowned legal scholar Elyn Saks, who built a celebrated career while living with schizophrenia. The free performances celebrate resilience and challenge stigma around serious mental illness.
Scientists at Rutgers have identified a gene variant that may explain why mental illnesses like schizophrenia and bipolar disorder run in families. The discovery could transform how doctors treat these conditions.
Showing 20 of 7233